Syntheses of fluorine-18 labeled inhibitors of GABA (γ-aminobutyric acid) reuptake
Creators
- 1. Univ. of Michigan, Ann Arbor (United States)
- 2. Warner-Lambert Co., Ann Arbor, MI (United States)
Description
GABA (γ-aminobutyric acid) is a major inhibitory neurotransmitter. GABA is involved in the control of neuronal activity in the central nervous system, and dysfunctions of the GABA system have been implicated in a number of neurological disorders, particularly epilepsy and other seizure disorders. To study the GABA system in vivo using PET, previous investigators have prepared a variety of radiolabeled ligands known to bind to the GABA/benzodiazepine receptor complex. In order to examine the presynapotic physiology of the GABA system, and perhaps assess the degeneration of GABAergic neurons in desease, the authors have now prepared fluorine-18 radiotracers with demonstrated affinity for the presynaptic reuptake system for GABA. The compounds, diarylmethoxyalkyl derivatives of the amino acid nipecotic acid (1,2,3), are sufficiently non-polar to penetrate the blood-brain barrier, and are potent in vivo inhibitors of GABA reuptake
Additional details
Publishing Information
- Imprint Title
- Eighth international symposium on radiopharmaceutical chemistry. Abstracts: Final report
- Imprint Pagination
- 458 p.
- Journal Page Range
- p. 399.
- Report number
- DOE/ER/60968--1
Conference
- Title
- 8. international symposium on radiopharmaceutical chemistry.
- Dates
- 24-29 Jun 1990.
- Place
- Princeton, NJ (United States).
INIS
- Country of Publication
- United States
- Country of Input or Organization
- United States
- INIS RN
- 23029829
- Subject category
- S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference, Non-conventional Literature
- Quality check status
- Yes
- Descriptors DEI
- ACTIVITY LEVELS; AMINOBUTYRIC ACID; BLOOD-BRAIN BARRIER; BRAIN; CHEMICAL PREPARATION; DIAGNOSIS; FLUORINE 18; HYDROLYSIS; IN VIVO; INHIBITION; ISOMERS; LABELLING; LIQUID COLUMN CHROMATOGRAPHY; MICE; MOLECULAR STRUCTURE; NERVOUS SYSTEM DISEASES; RADIOPHARMACEUTICALS; REDUCTION; THIN-LAYER CHROMATOGRAPHY; TISSUE DISTRIBUTION; UPTAKE;
- Descriptors DEC
- AMINO ACIDS; ANIMALS; AUTONOMIC NERVOUS SYSTEM AGENT; BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; CARBOXYLIC ACIDS; CENTRAL NERVOUS SYSTEM; CHEMICAL REACTIONS; CHROMATOGRAPHY; DECOMPOSITION; DISEASES; DISTRIBUTION; DRUGS; FLUORINE ISOTOPES; HOURS LIVING RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; LIGHT NUCLEI; MAMMALS; MATERIALS; NANOSEC LIVING RADIOISOTOPES; NERVOUS SYSTEM; NEUROREGULATORS; NUCLEI; ODD-ODD NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RADIOACTIVE MATERIALS; RADIOISOTOPES; RODENTS; SEPARATION PROCESSES; SOLVOLYSIS; SYNTHESIS; VERTEBRATES;
Optional Information
- Contract/Grant/Project number
- Contract AC02-76EV02031
- Secondary number(s)
- CONF-9006363--Absts.